Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye

Recruiting now · Phase 1

Conditions studied: Dry Eye Syndromes

In brief

The purpose of this study is to determine the safety and efficacy of Limbal Stem Cells derived Exosomes (LSC-Exo) in alleviation of dry eye symptoms

Key facts

Study ID

NCT06543667

Run by

Iran University of Medical Sciences

People needed

30

Starts

2024-08-01

Expected to finish

2026-07-01

Last updated by the study team

2025-05-01

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with complaints of burning or itching or feeling of a foreign body in the eye
• Moderate and severe dry eye severity
• Age between 18-70 years

You may not qualify if…

• Previous history of eye surgery
• Any disease that suppresses the immune system
• Pregnancy and breastfeeding
• Eyelid abnormalities
• Use of eye drops in the past year except artificial tears and lubricating ointments
• Use of systemic drugs that affect the tear film in last three months
• Use of contact lenses in the last three months

Where it is running

• Moheb Kowsar Hospital — Tehran, Iran (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.